找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Urologic Oncology; Axel S. Merseburger,Maximilian Burger Reference work 2019 Springer Nature Switzerland AG 2019 Bladder Cancer.Diagnosis.

[復(fù)制鏈接]
查看: 54391|回復(fù): 61
樓主
發(fā)表于 2025-3-21 18:53:33 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱(chēng)Urologic Oncology
編輯Axel S. Merseburger,Maximilian Burger
視頻videohttp://file.papertrans.cn/945/944309/944309.mp4
概述Provides evidence-based guidance on diagnosis, treatment, and prognosis.Explains the fundamental principles underlying the available diagnostic and treatment approaches.Covers the etiology and managem
圖書(shū)封面Titlebook: Urologic Oncology;  Axel S. Merseburger,Maximilian Burger Reference work 2019 Springer Nature Switzerland AG 2019 Bladder Cancer.Diagnosis.
描述.This comprehensive and timely textbook covers all aspects of the evidence-based management of genitourinary cancers and explains the fundamental principles underlying the available diagnostic and treatment approaches, including chemotherapy, radiotherapy, immunotherapy, and surgery. For each type of cancer – prostate, bladder, renal, testicular, and penile, plus rare urologic malignancies – clinical presentation, diagnosis, and treatment strategies are described in detail and information is provided on etiology, epidemiology, risk factors, and pathology, including TNM classification. Careful attention is also devoted to the complications that may be encountered when treating urologic malignancies and to the management of these complications. The text is complemented by the inclusion of numerous high-definition photographs and illustrations. .Urologic Oncology. will be a valuable reference and source of guidance for all oncologists, urologists and practitioners in related disciplines who treat patients with urologic cancers..
出版日期Reference work 2019
關(guān)鍵詞Bladder Cancer; Diagnosis; Oncology; Prostate Cancer; Treatment; Urology; Radiaton Oncology
版次1
doihttps://doi.org/10.1007/978-3-319-42623-5
isbn_ebook978-3-319-42623-5
copyrightSpringer Nature Switzerland AG 2019
The information of publication is updating

書(shū)目名稱(chēng)Urologic Oncology影響因子(影響力)




書(shū)目名稱(chēng)Urologic Oncology影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Urologic Oncology網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Urologic Oncology網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Urologic Oncology被引頻次




書(shū)目名稱(chēng)Urologic Oncology被引頻次學(xué)科排名




書(shū)目名稱(chēng)Urologic Oncology年度引用




書(shū)目名稱(chēng)Urologic Oncology年度引用學(xué)科排名




書(shū)目名稱(chēng)Urologic Oncology讀者反饋




書(shū)目名稱(chēng)Urologic Oncology讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:40:43 | 只看該作者
Clinical Trials and Their Principles in Urologic Oncologyand legal considerations..In this chapter, commonly applied trial designs and relevant aspects of designing clinical studies will be contemplated. The aim is to provide sufficient background needed for proper interpretation of research findings and translating clinical trial results into clinical pr
板凳
發(fā)表于 2025-3-22 03:37:24 | 只看該作者
Bone Target Therapy in Urologic Malignanciesed to prove a bone metastasis-preventing effect. The application of this agent in castration-sensitive PC is discussed controversially after a clinical trial has shown no benefit of zoledronic acid in this setting..In patients with advanced prostate cancer and multiple bone metastases, therapy with
地板
發(fā)表于 2025-3-22 05:22:57 | 只看該作者
5#
發(fā)表于 2025-3-22 12:30:29 | 只看該作者
6#
發(fā)表于 2025-3-22 14:48:49 | 只看該作者
7#
發(fā)表于 2025-3-22 18:30:52 | 只看該作者
8#
發(fā)表于 2025-3-22 22:58:55 | 只看該作者
9#
發(fā)表于 2025-3-23 04:14:04 | 只看該作者
10#
發(fā)表于 2025-3-23 09:10:16 | 只看該作者
Timothy Hua-Tse Cheng,Wayne Lam,Jeremy Yuen-Chun Teohgenics served as Exhibits Chairman. Local arrangements and conference management were expertly handled under the guidance of Centennial Conferences, Inc. Skillf978-1-4757-9061-0978-1-4757-9059-7Series ISSN 0065-2482
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 00:50
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
长沙县| 武定县| 丁青县| 汝州市| 新平| 开化县| 全南县| 江孜县| 广元市| 清远市| 建德市| 车致| 平泉县| 锡林郭勒盟| 库伦旗| 巴中市| 诏安县| 囊谦县| 天门市| 平邑县| 特克斯县| 团风县| 保德县| 泸溪县| 安国市| 新余市| 吉木乃县| 武义县| 沅陵县| 陈巴尔虎旗| 贡嘎县| 泸西县| 滨州市| 贵州省| 南开区| 崇明县| 汉寿县| 丹巴县| 东乌| 云林县| 交城县|